Exicure(NASDAQ:XCUR) 
Exicure, Inc., a clinical-stage biotechnology company, develops therapeutics for neurology, immuno-oncology, inflammatory diseases, and genetic disorders based on its proprietary spherical nucleic acid (SNA) technology. Its drug candidate includes cavrotolimod (AST-008) that is in a Phase 1b/2 clini...
Website: http://www.exicuretx.com
Founded: 2011
CEO: David Giljohann
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 12.84
H 13.37
L 12.68
C 13.00
V 5,755
10EMA 13.00
20EMA 13.00
60EMA 13.00
120EMA 13.00
250EMA 13.00